Peter Attia· MD
So, Mo Cara on here, he was talking about Nesto, which is the nasal formulation, which has such a short halflife that it's actually a T dosing schedule.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So, Mo Cara on here, he was talking about Nesto, which is the nasal formulation, which has such a short halflife that it's actually a T dosing schedule.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so that's you know slightly more than you would probably take if you were just doing it intramuscularly um but nevertheless um the the idea with it is it's quicker acting — and that's why you have to take it sort of three times a day because it's not sticking around like in a fat Depot the way an injectable Source would be
so that's you know slightly more than you would probably take if you were just doing it intramuscularly um but nevertheless um the the idea with it is it's quicker acting um and that's why you have to take it sort of three times a day because it's not sticking around like in a fat Depot the way an injectable Source would be